Mesosil develops and manufactures antimicrobial and bioactive additives for dental and medical materials.
Mesosil’s innovative silica-based platform enables high-capacity delivery and sustained release of bioactive agents, addressing critical challenges in infection prevention and biomaterial longevity. In dental materials, our technology reduces recurrent tooth decay by up to 80%. With applications in orthopedics, implantable devices, and other medical fields currently under evaluation, Mesosil is creating the next generation of long-term antimicrobial protection. Our platform seamlessly integrates into existing manufacturing and clinical workflows, offering a scalable, high-impact solution for the future of medical materials.
Company Details
- Employees
- 8
- Founded
- -
- Address
- 124 Edward St, Toronto,ontario M5g 1g6,canada
- Industry
- Nanotechnology Research
- NAICS
-
Research and Development in Nanotechnology
- Website
- https://www.mesosil.com/
- Keywords
- nanomaterials and dental materials.
- HQ
- Toronto, Ontario
Mesosil Questions
Mesosil's website is https://www.mesosil.com/
Mesosil's LinkedIn profile is https://ca.linkedin.com/company/mesosil
Mesosil has
8 employees.
View email and phone details for 8
employees at Mesosil.
Mesosil's industry is
Nanotechnology Research
Mesosil's top competitors are
Myant,
Spinup At Utm,
Ardra Inc,
Atorvia,
Blue-Zone Technologies,
Bough Biosciences,
Panaxium,
Mycofutures,
Immunobiochem Corporation,
Epiloid Biotechnology.
Mesosil's categories are Nanotechnology Research
Mesosil's founding year is 2018
